NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains
Go back to NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.04 +0.42 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.62 | 52 Week High | $9.54 | |||
| Open | $16.62 | 52 Week Low | $5.49 | |||
| Day High | $17.30 | P/E | 426.00 | |||
| Day Low | $16.54 | EPS | $0.04 | |||
| Volume | 1,493,569 | |||||



